CA2084331A1 - Methode et composition pour traiter les infections virales - Google Patents

Methode et composition pour traiter les infections virales

Info

Publication number
CA2084331A1
CA2084331A1 CA 2084331 CA2084331A CA2084331A1 CA 2084331 A1 CA2084331 A1 CA 2084331A1 CA 2084331 CA2084331 CA 2084331 CA 2084331 A CA2084331 A CA 2084331A CA 2084331 A1 CA2084331 A1 CA 2084331A1
Authority
CA
Canada
Prior art keywords
sequence
polypeptide
hiv
infection
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2084331
Other languages
English (en)
Inventor
Sudhakar S. Wagle
William J. Hermann, Jr.
Ali A. S. Gawish
S. Ken Tanaka
Thomas Steinbach
Carl H. Lawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2084331A1 publication Critical patent/CA2084331A1/fr
Abandoned legal-status Critical Current

Links

CA 2084331 1991-12-04 1992-12-02 Methode et composition pour traiter les infections virales Abandoned CA2084331A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80384491A 1991-12-04 1991-12-04
US803,844 1991-12-04
US96257092A 1992-10-14 1992-10-14
US962,570 1992-10-14

Publications (1)

Publication Number Publication Date
CA2084331A1 true CA2084331A1 (fr) 1993-06-05

Family

ID=27122645

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2084331 Abandoned CA2084331A1 (fr) 1991-12-04 1992-12-02 Methode et composition pour traiter les infections virales

Country Status (1)

Country Link
CA (1) CA2084331A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350472B1 (en) * 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350472B1 (en) * 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract

Similar Documents

Publication Publication Date Title
US4795739A (en) Method of inhibiting HIV
KR100571215B1 (ko) 복합적인치료요법을이용한hiv와다른바이러스감염의치료
US4869903A (en) Method of selectively inhibiting HIV
TSAI et al. Inhibition of human immunodeficiency virus infectivity by chloroquine
US5055296A (en) Method of treating chronic fatigue syndrome
AU689266B2 (en) Preparations for the treatment of Aids comprising peptides derived from a human protein Ezrin
EP0101200A2 (fr) Facteur de transfert pour utilisation dans le traitement d'infections virales
US5057325A (en) Method of inhibiting replication of HIV with water-soluble melanins
EP0537722A2 (fr) Polypeptides dérivés du foie porcin pour le traitement des infections virales
JPH05504774A (ja) エイズ治療を増進するためのメタロポルフィリン類の使用
US6011014A (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
CA2084331A1 (fr) Methode et composition pour traiter les infections virales
US5334395A (en) Method of treating an epstein-barr viral infection
US5316775A (en) Method of treating hepatitis B infection
Sato et al. A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice
EP0335726A2 (fr) Utilisation de thymopentine et de ses dérivés dans le traitement de patients atteints de l'HIV
JPH06128288A (ja) ポリペプチドおよびそれを含有するウイルス感染治療用医薬組成物
US4534966A (en) Composition for treating infectious diseases, gout or arteriosclerosis containing human pepsin and/or human leukocyte pepsin-like enzyme and method for using same
RU2130317C1 (ru) Линейные или циклические пептиды, их применение, способ лечения
AU719203B2 (en) Use of proteins as anti-retroviral agents
AP255A (en) A method of inoculation with an antigenic peptide.
AU696602B2 (en) Serum preparations for inhibiting retroviruses and tumor growth
Kitchen Effect of diethylcarbamazine on cats given feline leukaemia virus vaccine
US20010043928A1 (en) Serum preparations for inhibiting retroviruses and tumor growth
Rola-Pleszczynski et al. Induction of cytotoxic cell activity by peptide fragments of β2-microglobulin

Legal Events

Date Code Title Description
FZDE Dead